Results GLP-1 RAs significantly reduced the risk of composite outcomes at one year (Hazard Ratio, HR 0.784
Synergistic effect of nanoparticles with probiotics on gastrointestinal regenerative medicine
95% CI, 0.57 to 0.85) and 50% (HR, 0.56
This is one area where Ozempic and diverticulitis may work in your favor rather than against you
For BPC-157 specifically, the FDA reported limited and short human studies, a lack of adequate studies for several commonly used routes of administration, potential immunogenicity concerns, possible liver and clotting signals in animal studies, and three adverse-event reports, while noting that a cause could not be established
In an audience packed with senior R&D leadersincluding over 10 from Eli Lilly, alongside key figures from Novo Nordisk, AstraZeneca, Roche, Boehringer Ingelheim, and others the realization dawned that a traditional pharma giant had officially evolved into the first longevity pharma company